A Novel Variant of CORO1A Gene Contributing to the Development of Primary Immunodeficiency in Children

Alanoud Aljohani1, Yazeed Alayed2, Bashayer Alrasheed1

  • 1Pediatric Allergy and Immunology Consultant, Department of Allergy and Immunology, Main Children Hospital, King Fahad Medical City, P.O. Box. 59046, Riyadh, 11525, Saudi Arabia, kfmc.med.sa.

Insights

This case report details a novel homozygous variant in the coronin 1A (CORO1A) gene linked to atypical severe combined immunodeficiency (SCID). The findings expand the understanding of CORO1A deficiency and its varied clinical presentations.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Severe combined immunodeficiency (SCID) is a group of rare genetic disorders characterized by profound defects in T-cell and B-cell function.
  • CORO1A gene variants are known to cause autosomal recessive SCID, but atypical presentations are increasingly recognized.

Purpose of the Study:

  • To report a novel homozygous variant in the CORO1A gene in a pediatric patient with recurrent infections and unique immunological findings.
  • To characterize the clinical and immunological phenotype associated with this novel CORO1A variant.

Main Methods:

  • Case report of a 9-year-old female with recurrent pneumonia and urinary tract infections.
  • Comprehensive immunological evaluation including T-cell lymphocytosis, B-cell lymphopenia, and low CD4/CD8 ratio.
  • Genetic testing identifying a homozygous variant of uncertain significance (VUS) in the CORO1A gene.

Main Results:

  • The patient presented with recurrent infections, periodic T-cell lymphocytosis, T- and B-cell lymphopenia, and a low CD4/CD8 ratio.
  • A novel homozygous variant in the CORO1A gene was identified.
  • This variant is associated with an atypical form of SCID, expanding the known spectrum of CORO1A deficiency.

Conclusions:

  • A novel homozygous CORO1A variant is linked to an atypical SCID phenotype.
  • This case highlights the importance of genetic testing in diagnosing primary immunodeficiencies with unusual immunological profiles.
  • The findings contribute to a broader understanding of CORO1A-related SCID and its genetic basis.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...